SEATTLE, July 27, 2017 -- Redfin Corporation (NASDAQ:RDFN), a technology-powered residential real estate brokerage, today announced the pricing of its initial public offering of 9,231,000 shares of its common stock at a price of $15.00 per share. All of the shares are being offered by Redfin. The shares are expected to begin trading on The NASDAQ Global Select Market under the symbol “RDFN” on July 28, 2017. In addition, Redfin has granted the underwriters a 30-day option to purchase up to an additional 1,384,650 shares of common stock at the initial public offering price.
Goldman Sachs & Co. LLC and Allen & Company LLC are acting as lead book-running managers for the offering. BofA Merrill Lynch and RBC Capital Markets are also acting as book-running managers for the offering, and Oppenheimer & Co. and Stifel are acting as co-managers.
The offering is being made only by means of a prospectus. A copy of the final prospectus, when available, may be obtained from Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, or by telephone at (866) 471-2526, or by facsimile at (212) 902-9316, or by email at [email protected]; or from Allen & Company LLC, Attention: Prospectus Department, 711 Fifth Avenue, 10th Floor, New York, NY 10022, or by telephone at (212) 339-2220, or by email at [email protected].
A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Contacts Investor Relations Elena Perron, 206-576-8333 [email protected] Public Relations Jani Strand or Rachel Musiker, 206-588-6863 [email protected]


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 



